GEOVAX LABS, INC. Operating Leases, Future Minimum Payments, Due in Two Years
GEOVAX LABS, INC. (GOVX) had Operating Leases, Future Minimum Payments, Due in Two Years of $161.27 thousand as of 2018-12-31, per its 10-K filed 2019-03-26.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInTwoYears · last filed 2019-03-26
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $161.27K.
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Two Years $161.27K.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Two Years $156.54K.
- 2017-09-30: Operating Leases, Future Minimum Payments, Due in Two Years $156.54K.
| Period end | Operating Leases, Future Minimum Payments, Due in Two Years |
|---|---|
| 2018-12-31 | $161.27K 10-K · filed 2019-03-26 |
| 2018-09-30 | $161.27K 10-Q · filed 2018-11-08 |
| 2017-12-31 | $156.54K 10-K · filed 2018-03-23 |
| 2017-09-30 | $156.54K 10-Q · filed 2017-11-09 |
| 2017-06-30 | $156.54K 10-Q · filed 2017-08-14 |
| 2016-09-30 | $151.99K 10-Q · filed 2016-11-14 |
| 2015-09-30 | $149.04K 10-Q · filed 2015-11-12 |
| 2013-09-30 | $128.92K 10-Q · filed 2013-11-12 |
| 2013-06-30 | $128.92K 10-Q · filed 2013-08-12 |
| 2013-03-31 | $128.92K 10-Q · filed 2013-05-01 |
| 2012-12-31 | $128.92K 10-K · filed 2013-03-18 |
| 2012-09-30 | $125.18K 10-Q · filed 2012-11-13 |
| 2012-03-31 | $125.18K 10-Q · filed 2012-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |